Hudson Valley Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,280
Closed -$253K 162
2018
Q3
$253K Hold
3,280
0.06% 128
2018
Q2
$232K Sell
3,280
-240
-7% -$16.9K 0.06% 132
2018
Q1
$265K Sell
3,520
-1,030
-23% -$81.9K 0.07% 129
2017
Q4
$326K Sell
4,550
-2,370
-34% -$180K 0.08% 125
2017
Q3
$561K Sell
6,920
-615
-8% -$47K 0.15% 108
2017
Q2
$533K Sell
7,535
-755
-9% -$50.2K 0.15% 108
2017
Q1
$563K Sell
8,290
-475
-5% -$33.4K 0.16% 107
2016
Q4
$628K Sell
8,765
-10,365
-54% -$770K 0.19% 98
2016
Q3
$1.51M Buy
19,130
+645
+3% +$52.4K 0.47% 64
2016
Q2
$1.54M Buy
18,485
+2,085
+13% +$185K 0.49% 60
2016
Q1
$1.51M Buy
16,400
+2,895
+21% +$261K 0.49% 57
2015
Q4
$1.37M Buy
13,505
+3,830
+40% +$399K 0.43% 62
2015
Q3
$950K Buy
9,675
+5,994
+163% +$666K 0.31% 77
2015
Q2
$431K Buy
+3,681
New +$402K 0.13% 105

Other funds holding GILD

Hudson Valley Investment Advisors's GILD Position: Q4 2018 in Review

Hudson Valley Investment Advisors sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 3,280 shares — an estimated $253K sold.

Hudson Valley Investment Advisors first reported a position in GILD in Q2 2015 and held it in 14 quarters. The position peaked at $1.54M in Q2 2016. 1,497 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Hudson Valley Investment Advisors reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Hudson Valley Investment Advisors sold 3,280 Gilead Sciences shares in Q4 2018, an estimated $253K.
  • Hudson Valley Investment Advisors first reported a position in Gilead Sciences in Q2 2015 and held it in 14 quarters.
  • Hudson Valley Investment Advisors's Gilead Sciences position peaked at $1.54M in Q2 2016.
  • 1,497 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Hudson Valley Investment Advisors's 13F filing for Q4 2018, filed 17 Jan 2019.